Development and validation of HIV SMRTcap for the characterization of HIV-1 reservoirs across tissues and subtypes.
Sadri G, Nadakal ST, Lauer W, Kos J, Singh PK, Elliott EM, Kaiser CW, Ford EE, Richardson N, Hudson E, Linden NL, Danesh A, Powell J, Warburton P, Soto J, Emery M, Deikus G, Lee GQ, Lamers SL, Reynolds SJ, Galiwango R, Prodger JL, Tomusange S, Kityamuweesi T, Han T, Jones RB, Tobian AAR, Engelman AN, Sebra R, Morgello S, Redd AD, Sachs D, Rouchka E, Smith ML.
Sadri G, et al.
bioRxiv [Preprint]. 2025 May 5:2025.05.01.651657. doi: 10.1101/2025.05.01.651657.
bioRxiv. 2025.
PMID: 40654951
Free PMC article.
Updated.
Preprint.
Moreover, we demonstrate here that HIV SMRTcap performs robustly across the major global subtypes (HIV-1 subtype A, B, C, D and A/D recombinant viruses), and can use both cell- and tissue-derived inputs, including samples from antiretroviral therapy (ART) treated in …
Moreover, we demonstrate here that HIV SMRTcap performs robustly across the major global subtypes (HIV-1 subtype A, B, C, D and A/ …